Wolverine Asset Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Wolverine Asset Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Sell	154,544 -16,154	-9%	-$87.4K	0.01%	700
2026 Q1	$306K	Buy	170,698 +15,829	+10%	+$30.7K	﹤0.01%	1024
2025 Q4	$146K	Buy	154,869 +84,520	+120%	+$47.6K	﹤0.01%	1148
2025 Q3	$21.1K	Hold	70,349	–	–	﹤0.01%	1293
2025 Q2	$18.5K	Hold	70,349	–	–	﹤0.01%	1322
2025 Q1	$2.67K	Hold	70,349	–	–	﹤0.01%	1415
2024 Q4	$12.7K	Hold	70,349	–	–	﹤0.01%	1334
2024 Q3	$9.85K	Hold	70,349	–	–	﹤0.01%	1328
2024 Q2	$7.18K	Hold	70,349	–	–	﹤0.01%	1365
2024 Q1	$12.8K	Hold	70,349	–	–	﹤0.01%	1260
2023 Q4	$23.2K	Buy	+70,349	New	+$31.4K	﹤0.01%	1299

Other funds holding RVMDW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Wolverine Asset Management's RVMDW Position: Q2 2026 in Review

Wolverine Asset Management reduced its Revolution Medicines Inc Warrant (RVMDW) stake by 9.5% in Q2 2026, selling an estimated $87.4K and leaving 154,544 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #700.

Wolverine Asset Management first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

Wolverine Asset Management held 154,544 shares of Revolution Medicines Inc Warrant worth $1.45M as of Q2 2026.
Wolverine Asset Management sold 16,154 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $87.4K.
Revolution Medicines Inc Warrant made up 0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #700 holding.
Wolverine Asset Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.